|QUALITY||INITIATIVE||PROFESSIONALISM||QUALITY OF LIFE|
We are excited to announce that Ockham has merged with Chiltern to lead the industry in Oncology, Source, and Biopharmaceutics development. The new Chiltern is a leading, global, mid-sized CRO focused on providing expertise, engagement, and tailored, responsive solutions to meet the demands of biotech and pharmaceutical partners of all sizes. In the coming weeks, we will be working together to integrate a strong harmonized organization. Today, and in the future, you may continue to expect the same great service to which you’re accustomed from each company. Please read more about our merger here.
|click here for chiltern.com||click here for Press Release||click here for ockham.com|